Analysts Set Sotera Health (NASDAQ:SHC) Target Price at $16.08

Sotera Health (NASDAQ:SHC) has received a consensus recommendation of “Moderate Buy” from the six brokerages that are covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $16.08.

SHC has been the topic of a number of research analyst reports. Royal Bank of Canada reaffirmed an “outperform” rating and set a $17.00 target price on shares of Sotera Health in a report on Thursday, November 21st. Barclays reduced their price objective on Sotera Health from $18.00 to $17.00 and set an “overweight” rating on the stock in a research note on Tuesday, February 18th. The Goldman Sachs Group began coverage on shares of Sotera Health in a research note on Friday, December 6th. They set a “neutral” rating and a $14.00 target price for the company. Finally, Citigroup raised their price target on shares of Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, November 6th.

Sotera Health Stock Performance

Shares of Sotera Health stock opened at $13.64 on Friday. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. Sotera Health has a 1 year low of $10.71 and a 1 year high of $17.44. The firm’s 50-day simple moving average is $13.48 and its 200-day simple moving average is $14.54. The firm has a market cap of $3.86 billion, a PE ratio of 54.56 and a beta of 1.91.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Blue Trust Inc. increased its holdings in shares of Sotera Health by 164.3% during the fourth quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock valued at $25,000 after purchasing an additional 1,140 shares during the period. Quarry LP bought a new position in Sotera Health in the 4th quarter valued at about $28,000. True Wealth Design LLC acquired a new position in Sotera Health during the 3rd quarter valued at about $32,000. GAMMA Investing LLC raised its position in shares of Sotera Health by 37.5% during the 4th quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock worth $56,000 after buying an additional 1,121 shares in the last quarter. Finally, Tower Research Capital LLC TRC lifted its stake in shares of Sotera Health by 37.8% in the 4th quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company’s stock worth $82,000 after acquiring an additional 1,640 shares during the period. Institutional investors own 91.03% of the company’s stock.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.